Advertisement

Parasitology Research

, Volume 112, Issue 3, pp 909–915 | Cite as

Application of praziquantel in schistosomiasis japonica control strategies in China

  • Wei Wu
  • Yixin HuangEmail author
Review

Abstract

Schistosomiasis remains a major public health problem with an estimated 200 million people infected in the world, and in China, schistosomiasis japonica is endemic in the south part of the country. In 1960s, before praziquantel was developed, there were about seven million patients. Praziquantel has a high efficacy against Schistosoma, few and transient side effects, simple administration and competitive cost, and is equally suited for both individual and large-scale treatment. Praziquantel has been widely used in the morbidity control, transmission control, and prevention of schistosomiasis japonica in China since 1980s. The schemes of praziquantel chemotherapy include the diagnostic selective chemotherapy, extensive chemotherapy, mass chemotherapy, stratified chemotherapy, phased chemotherapy, etc. Chemotherapy alone or combined with other control measure, such as Oncomelania snail control, health education, safety water supply, and so on, has achieved a great success, and there are only 0.33 million infected people now. This paper reviews the application of praziquantel in the schistosomiasis japonica control strategies in China so as to provide the rich experiences for reference of health workers of other countries where schistosomiasis is endemic.

Keywords

Infection Rate Schistosomiasis Praziquantel Risk Zone Fecal Examination 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Andrews P, Thomas H, Pohlke R, Seubert J (1983) Praziquantel. Med Res Rev 3:147–200PubMedCrossRefGoogle Scholar
  2. Bonesso-Sabadini PI, de Souza Dias LC (2002) Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel. Mem Inst Oswaldo Cruz 97:381–385PubMedCrossRefGoogle Scholar
  3. Cao MK, Chen SH, Tian ZY, Xiao JW (1985) Effect of chemotherapy on schistosomiasis control in Wuyi Village of Hanshou County. Hunan Medicine 2:50Google Scholar
  4. Chen MG (2005) Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience. Acta Trop 96:168–176PubMedCrossRefGoogle Scholar
  5. Chen XY, Jiang QW, Guo JP, Zhao GM, Yuan HC (2000) Analysis of effectiveness of chemotherapy on schistosomiasis control in marshland regions. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 12:8–11Google Scholar
  6. Chitsulo L, Engels D, Montresor A, Savioli L (2000) The global status of schistosomiasis and its control. Acta Trop 77:41–51PubMedCrossRefGoogle Scholar
  7. Cioli D, Pica-Mattoccia L (2003) Praziquantel. Parasitol Res 90:S3–S9PubMedGoogle Scholar
  8. Fallon PG, Doenhoff MJ (1994) Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. AmJTrop Med Hyg 51:83–88Google Scholar
  9. Fallon PG, Sturrock RF, Niang AC, Doenhoff MJ (1995) Diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. AmJTrop Med Hyg 53:61–62Google Scholar
  10. Gong ZB, Yang JL, Zhao YF, Yang TZ (1999) Schistosomiasis endemic situation after mass chemotherapy stopping in hilly endemic areas. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 11:300–301Google Scholar
  11. Gönnert R, Andrews P (1977) Praziquantel, a new broad-spectrum antischistosomal agent. Parasitol Res 52:129–150Google Scholar
  12. Gray DJ, Williams GM, Li Y, Chen H, Forsyth SJ, Li RS, Barnett AG, Guo J, Ross AG, Feng Z, McManus DP (2009) A cluster-randomised intervention trial against Schistosoma japonicum in the People's Republic of China: bovine and human transmission. PLoS One 4:e5900PubMedCrossRefGoogle Scholar
  13. Grover JK, Vats V, Uppal G, Yadav S (2001) Anthelmintics: a review. Trop Gastroenterol 22:180–189PubMedGoogle Scholar
  14. Guo JD, Xie JF, Song M, Yang WP (1999) Effect of praziquantel chemotherapy on schistosomiasis control in population in Anhui Province. Chin J Parasit Dis Con 12:313–314Google Scholar
  15. Huang FP, Wu ZD, Zhang SJ, Xie ZW, Zhang SR (1996) Effect of chemotherapy on schistosomiasis control in 28 monitoring sites of World Bank Loan Project for schistosomiasis control in Jiangxi Province. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 8:299–301Google Scholar
  16. Huang XH, Gao B, Huang FP, Jiang SD (1998a) Comparative study on cost-effectiveness of three schistosomiasis control strategies in heavy endemic areas. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 10:97–98Google Scholar
  17. Huang YX, Rong GR, Xu GY, Wang XD, Yang HM, Song HT, Zhang XB, Tu YX (1998b) Mass praziquantel chemoprophylaxis against acute schistosomiasis japonica in a flood. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 10:138–140Google Scholar
  18. Huang YX, Xiao SH (2008) Praziquantel, an anthelmintic drug: research and application. People’s Medical Publishing House, Beijing, pp 1–16Google Scholar
  19. Ismail M, Metwally A, Farghaly A, Bruce J, Tao LF, Bennett JL (1996) Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. AmJTrop Med Hyg 55:214–218Google Scholar
  20. Ismail MM, Taha SA, Farghaly AM, el-Azony AS (1994) Laboratory induced resistance to praziquantel in experimental schistosomiasis. J Egypt Soc Parasitol 24:685–695PubMedGoogle Scholar
  21. Kumar V, Gryseels B (1994) Use of praziquantel against schistosomiasis: a review of current status. Int J Antimicrob Agents 4:313–320PubMedCrossRefGoogle Scholar
  22. Lei ZL, Zheng H, Zhang LJ, Zhu R, Guo JG, Li SZ, Wang LY, Chen Z, Zhou XN (2011) Schistosomiasis status in People's Republic of China in 2010. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 23:599–604PubMedGoogle Scholar
  23. Li YL, Chen XL, Lin PD, Chen Y (1994) Effect of chemotherapy alone on schistosomiasis control in hilly endemic region. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 6:222–223Google Scholar
  24. Liang YS, Dai JR, Ning A, Yu DB, Xu XJ, Zhu YC, Coles GC (2001) Susceptibility of Schistosoma japonicum to praziquantel in China. Trop Med Int Health 6:707–714PubMedCrossRefGoogle Scholar
  25. Lin DD, Jiang QW, Liu YM, Gao ZL, Xie ZW, Hu LS, Ni A, Wu ZD, Zhou SY, Qiu YX, Hu GH, Zhang SJ (1997) The analysis of cost-effectiveness for different chemotherapy strategies in the heavy endemic areas with schistosomiasis in Poyang Lake region, Jiangxi Province. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 9:135–138Google Scholar
  26. Ministry of Health of the People's Republic of China (1964) Handbook of schistosomiasis control. 1st Shanghai: Shanghai Scientific & Technical Publishers, Shanghai, p 1Google Scholar
  27. Ning A, Zhao GM, Li ZH, Jiang QW, Hu LS, Gu XN, He N, Zhang SJ, Wang XF, Yuan HC (1996) A longitudinal study on morbidity control of schistosomiasis by mass chemotherapy. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 8:197–200Google Scholar
  28. Redman CA, Robertson A, Fallon PG, Modha J, Kusel JR, Doenhoff MJ, Martin RJ (1996) Praziquantel: an urgent and exciting challenge. Parasitol Today 12:14–20PubMedCrossRefGoogle Scholar
  29. Seto EY, Wong BK, Lu D, Zhong B (2001) Human schistosomiasis resistance to praziquantel in China: should we be worried? AmJTrop Med Hyg 85:74–82CrossRefGoogle Scholar
  30. Seubert J, Pohlke R, Loebich F (1977) Synthesis and properties of praziquantel, a novel broad spectrum anthelmintic with excellent activity against schistosomes and cestodes. Experientia 33:1036–1037PubMedCrossRefGoogle Scholar
  31. She L, Wen YL (1998) Effect of extensive chemotherapy on schistosomiasis after dam burst in a flood in marshland endemic areas. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 10:165Google Scholar
  32. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6:411–425PubMedCrossRefGoogle Scholar
  33. Stephenson I, Wiselka M (2000) Drug treatment of tropical parasitic infections: recent achievements and developments. Drugs 60:985–995PubMedCrossRefGoogle Scholar
  34. Su DL, Xu ZY, Yang HC (1986) Comparative trials of schistosomiasis control in lake endemic region of Guichi County. In: Zheng G (ed) Advances in epidemiology of schistosomiasis in China from 1980 to 1985. Jiangsu Medicine Press, Nanjing, pp 23–29Google Scholar
  35. Sun LP, Cao J, Zhou XN, Gu BL (1995) Effect of selective chemotherapy on schistosomiasis transmission in marshland areas. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 7:248Google Scholar
  36. Wang QZ, Zhang SQ, Wang TP, Xiao X, Zhang GH, Lu DB, Zhu CG, Fang GR, Su GB, Yao ZQ (2000) Longitudinal study on schistosomiasis control effect of extended chemotherapy combined with health education in island endemic area. J Pract Parasitosis 8:49–52Google Scholar
  37. Wang YH, Zhang XH, Wang Y (1992) Longitudinal observation on chemotherapy alone in schistosomiasis control in lake endemic region. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 4:358–359Google Scholar
  38. Wang ZH, Yi ZH, Zhang YH, Su ZW, Huang XB, Hu J, Wang JS, Xiang CP (1998) Strategies and schedules with praziquantel for schistosomiasis control. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 10:203–206Google Scholar
  39. World Health Organization (1993) The control of schistosomiasis: Second Report of WHO Expert Committee. WHO Technical Report Series 830, Geneva: WHO 58–59Google Scholar
  40. World Health Organization (2002) Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. WHO Technical Report Series 912 Geneva: WHO 29–30Google Scholar
  41. Wu W, Wang W, Huang YX (2011) New insight into praziquantel against various developmental stages of schistosomes. Parasitol Res 109:1501–1507PubMedCrossRefGoogle Scholar
  42. Wu WD, Wang PN, Guan JZ, Xu LF, Mei JD, Tao CG, Ma WJ, Tin NW, Qin XY, Xu WJ, An JS, Lu GY (1990) Study on chemotherapy and Oncomelania snail control at risk zones for schistosomiasis control in lake region. In: Committee of Schistosomiasis of Ministry of Health, People's Republic of China (ed) Collection of data of schistosomiasis research. Nanjing University Press House, Nanjing, p 52Google Scholar
  43. Xiao JW, Tian ZY (1994) Effect of extensive chemotherapy combined with safe water modification on schistosomiasis control. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 6:360–361Google Scholar
  44. Xie MS, Wang FH, Zhou DR, Chen Y, Li YY, Peng AG, Li SQ, Yang RQ (1996) Effect of chemotherapy in residents and domestic animals on schistosomiasis in Dongting region, Hunan Province. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 8:106–107Google Scholar
  45. Xu FN, Wang TP, Qing XY, Mei JD, Cui XM, Chen DL, He JC, Xiao X, Zhou L, Fang GR, Lu GY, Xu WJ, Zhong DM, Xu YX (1990) Study on the interruption of transmission of schistosomiasis by the elimination of infection source. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2:11–16Google Scholar
  46. Yu DB, Li Y, Sleigh AC, Yu XL, Li YS, Wei WY, Liang YS, McManus DP (2001) Efficacy of praziquantel against Schistosoma japonicum: field evaluation in an area with repeated chemotherapy compared with a newly identified endemic focus in Hunan, China. Trans R Soc Trop Med Hyg 95:537–541PubMedCrossRefGoogle Scholar
  47. Yu SL, Dai YH, Yao JM, Chen LG, Xiang HY, Su YX, Zeng LZ (2002) Comparative study on the cost-effectiveness of two approaches of schistosomiasis control during three years in two villages in Hubei. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 14:208–212Google Scholar
  48. Yuan HC, Zhang SJ, Liu ZD, Jiang QW, Yang QJ, Hu LS, Wu ZD, Zhao GM (1995) Study on epidemiology and optimal strategies for control of schistosomiasis japonica in lake marshlands region. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 7:193–201Google Scholar
  49. Zeng XJ, Wu FD, Zhang SJ, Wu GL, Jiang WS, Yan X, Chen HG, Xiong YL, Yuan JH, Peters PA (1996) Observation on reinfection with Schistosoma japonicum in residents with higher prevalence in island region after selective treatment. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 8:83–86Google Scholar
  50. Zhang SJ, Murakami H, Lin DD, Wu ZD, Ning A, Hu F, Gu XN, Hu GH, Gao ZL, Chen TH (1997) Longitudinal study on schistosomiasis control in lake regions by mass chemotherapy combined with health education. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 9:342–345Google Scholar
  51. Zhang YH, Yi ZH, Gao SN, Fai HP, Lu M, Rao HF, Mao GX, Wang ZH, Wu J, Wang HC, Ma BB, Xiang CP (1995) Effect of chemotherapy of residents and domestic animals once on schistosomiasis japonica control. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 7:362Google Scholar
  52. Zhao GM, Jiang QW, Zhang SJ, Wu ZD, Liu ZDXGG, Hu LS, Yang QJ, Wei JG, Yuan HC (1995) Alternation in prevalence, intensity of infection and morbidity due to Schistosoma japonicum infection in a community following selective chemotherapy. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 7:267–269Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Jiangsu Institute of Parasitic DiseasesWuxi CityPeople’s Republic of China

Personalised recommendations